SCHEMBL927353

SCHEMBL927353

CC(C(=O)O)(c1ccc(C(=O)O)cc1)c1ccc(C(=O)O)cc1

nearest known ligand 0.61

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SRD5A2 P31213 4/20 0.61
RARB P10826 1/20 0.55
RARG P13631 1/20 0.55
TP53 P04637 1/20 0.55
TSHR P16473 1/20 0.55
MEN1 O00255 1/20 0.53
CYP1A2 P05177 1/20 0.53
KMT2A Q03164 1/20 0.53
NR1H4 Q96RI1 3/20 0.52
EPHX2 P34913 2/20 0.52
RXRA P19793 3/20 0.50
RXRB P28702 3/20 0.50
ALDH1A1 P00352 1/20 0.50
SMN1; SMN2 Q16637 1/20 0.50
RXRG P48443 1/20 0.50
TDP1 Q9NUW8 1/20 0.49
CA1 P00915 3/20 0.46
CA2 P00918 3/20 0.46
CA12 O43570 1/20 0.46
CA3 P07451 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9514865 0.94 SRD5A2 (0.55) SRD5A2RARBRARGTP53TSHR
SCHEMBL9130779 0.82 SRD5A2 (0.61) SRD5A2RARBRARGTP53TSHR
SCHEMBL18077481 0.81 SRD5A2 (0.65) SRD5A2RARBRARGTP53TSHR
SCHEMBL36693 0.81 SRD5A2 (0.87) SRD5A2RARBRARGTP53TSHR
SCHEMBL11772204 0.81 SRD5A2 (0.65) SRD5A2RARBRARGTP53TSHR
SCHEMBL71433 0.81 SRD5A2 (0.65) SRD5A2RARBRARGTP53TSHR
SCHEMBL28403846 0.81 SRD5A2 (0.54) SRD5A2RARBRARGTSHRMEN1
SCHEMBL1635858 0.81 SRD5A2 (0.65) SRD5A2RARBRARGTP53TSHR
SCHEMBL6243188 0.80 SRD5A2 (0.59) SRD5A2RARBRARGTP53TSHR
Terephthalic Acid SCHEMBL10332533 0.80 TSHR (0.75) SRD5A2RARBRARGTP53TSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20110003955-A1 Imide Oligomer And Polyimide Resin Obtained By Thermal Curing Thereof DAIWA CAN COMPANY (JP) 2011-01-06 US claimed
EP-2246383-A1 IMIDE OLIGOMER AND POLYIMIDE RESIN OBTAINED BY THERMAL CURING THEREOF DAIWA CAN COMPANY (JP) 2010-11-03 EP claimed
US-20110003955-A1 Imide Oligomer And Polyimide Resin Obtained By Thermal Curing Thereof DAIWA CAN COMPANY (JP) 2011-01-06 US disclosed
EP-2246383-A1 IMIDE OLIGOMER AND POLYIMIDE RESIN OBTAINED BY THERMAL CURING THEREOF DAIWA CAN COMPANY (JP) 2010-11-03 EP disclosed
US-4031167-A COATINGS INTERNATIONAL TELEPHONE AND TELEGRAPH CORPORATION (US) 1977-06-21 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110003955-A1 Imide Oligomer And Polyimide Resin Obtained By Thermal Curing Thereof PUF60, SMARCC2, SMARCA4 SRD5A2 3843/4885RARB 3301/4885RARG 3413/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.